Spruce Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Spruce Biosciences generated cash of -$33,275,000, which is more than the previous year. Cash used in financing activities reached the amount of $49,140,000 last year. Net change in cash is therefore $71,642,000.
Cash Flow
| 2018 | -8.57M | 0 | 0 |
|---|---|---|---|
| 2019 | -12.61M | -4K | 12.43M |
| 2020 | -27.51M | -74K | 181.03M |
| 2021 | -35.87M | -79.16M | 643K |
| 2022 | -41.68M | 23.69M | -241K |
| 2023 | -33.27M | 55.77M | 49.14M |
SPRB Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 24.73M | 42.96M | 157.36M | 3.92M | 4.11M | 12.68M |
Operating activities | ||||||
Net income | -47.91M | -46.18M | -42.29M | -29.53M | -13.08M | -9.85M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 70K | 74K | 68K | 36K | 12K | 1K |
Stock-based compensation expense | 4.62M | 3.63M | 3.95M | 755K | 196K | 0 |
| Deferred income tax benefit | 4.62M | 3.63M | 3.95M | 755K | 196K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 1.90M | -1.39M | 1.14M | 3.73M | -226K | 1.69M |
Cash generated by operating activities | -33.27M | -41.68M | -35.87M | -27.51M | -12.61M | -8.57M |
Investing activities | ||||||
Purchases Of Investments | -11.88M | -36.8M | -79.07M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -7K | -8K | -93K | -74K | -4K | 0 |
Acquisitions Net | 0 | -23.7M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 55.77M | 23.69M | -79.16M | -74K | -4K | 0 |
Financing activities | ||||||
Common Stock Issued | 53.61M | -201K | 423K | 96.25M | 12.43M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -40K | 0 | 0 | 0 | 0 |
Repayments of term debt | -1.62M | 0 | -230K | 0 | 4.49M | 0 |
Cash used in financing activities | 49.14M | -241K | 643K | 181.03M | 12.43M | 0 |
Net Change In Cash | 71.64M | -18.23M | -114.40M | 153.44M | -188K | -8.57M |
Cash at end of period | 96.37M | 24.73M | 42.96M | 157.36M | 3.92M | 4.11M |
| Data source | Data source | Data source | Data source |